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Available online 8 February 2019Background: Suicide is a major issue for global public health. Suicidality describes a broad spectrum of thoughts
and behaviours, some of which are common in the general population. Although suicide results from a complex
interaction of multiple social and psychological factors, predisposition to suicidality is at least partly genetic.
Methods: Ordinal genome-wide association study of suicidality in the UK Biobank cohort comparing: ‘no
suicidality’ controls (N= 83,557); ‘thoughts that life was not worth living’ (N = 21,063); ‘ever contemplated
self-harm’ (N = 13,038); ‘act of deliberate self-harm in the past’ (N = 2498); and ‘previous suicide attempt’
(N= 2666).
Outcomes:We identiﬁed three novel genome-wide signiﬁcant loci for suicidality (on chromosomes nine, 11 and
13) and moderate-to-strong genetic correlations between suicidality and a range of psychiatric disorders, most
notably depression (rg 0·81).
Interpretation: Theseﬁndings provide new information about genetic variants relating to increased risk of suicidal
thoughts and behaviours. Future work should assess the extent to which polygenic risk scores for suicidality, in
combinationwith non-genetic risk factors, may be useful for stratiﬁed approaches to suicide prevention at a pop-
ulation level.
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Suicide is a major and growing issue for global public health. Annu-
ally, approximately 800,000 people die by suicide and 20 times this
number will attempt suicide during their lifetime [1]. ‘Suicidality’ en-
compasses a broad range of experiences and behaviours, from suicidal
ideas/thoughts, to acts of deliberate self-harm and suicide attempts, oc-
curring along a spectrum towards completed suicide [2]. Somellbeing, University of Glasgow,
2 8RZ, UK.
th).
. This is an open access article undercomponents of suicidal thoughts and behaviours, such as feeling that
life is not worth living or contemplating self-harm, are relatively com-
mon in the general population, as well as in patients affected by a vari-
ety of separate clinical diagnoses. Suicidality can therefore be
considered a complex dimensional trait that ﬁts within a Research Do-
main Criteria (RDoC) approach because it cuts across traditional psychi-
atric diagnostic classiﬁcations.
Pathways to completed suicide are complex and multifactorial [3].
Suicidal thoughts and actions are a consequence of a dynamic interplay
between genetic, other biological, psychiatric, psychological, and awide
range of important social, economic and cultural factors [4]. Clinically,
deliberate self-harm (DSH) is a major risk factor for subsequent suicidal
behaviour. It is also recognised that substance abuse-related disordersthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
Research in context
Evidence before this study
To date genetic studies of suicidal behaviour (ideation, attempt,
completion) have mainly been conducted in individuals with se-
vere mental illness and the few findings reported have failed to
replicate in subsequent studies.
Added value of this study
This is the first study to explore the genetics of a broad suicidality
phenotype within a large population-based cohort (N= 122 k in-
dividuals). Mutually exclusive categories of ‘no suicidal behav-
iour’, ‘contemplated self-harm’, ‘actual self-harm’, ‘suicidal
ideation’ and ‘suicide attempt’ were assessed in an ordinal
genome-wide association study (GWAS). A risk score of
suicidality demonstrated associationswith an independent subset
of completed suicide. Moderate-to-strong genetic correlations
were observed with all major psychiatric traits. Separate GWAS
analyses of deliberate self-harm or suicide ideation and attempts
suggested that the genetic contributions to these traits have dis-
tinct components. In a recent independent study of suicide at-
tempts, the lead genetic variant identified in our study
demonstrated consistent replication of effect size and direction.
Implications
This is the first report of robust genetic associations with
suicidality and has the potential to lead to improved understanding
of biological mechanisms underlying suicidal thoughts and behav-
iour. Further exploration of the impact of genetic risk scores in
combination with clinical, social and environmental factors is
now warranted.
518 R.J. Strawbridge et al. / EBioMedicine 41 (2019) 517–525and mood disorders are particularly associated with suicide risk [5].
Similarly, early adversities such as childhood sexual abuse [6],maladap-
tive parenting [7] and parental loss [8] all contribute to suicidal thoughts
and behaviours, either directly or by increasing the risk of psychiatric
disorders [9,10]. Personality-level traits such as neuroticism, impaired
decision-making and sensitivity to negative social stimuli also contrib-
ute to suicidality [11].
Family, adoption and twin studies suggest a heritability estimate for
suicidal behaviour of approximately 38–55% [12], and thus suicidality as
a behavioural trait is amenable to genetic investigation. Heritability es-
timates for less clearly deﬁned phenotypes such as suicidal thoughts are
difﬁcult to establish [13]. It is clear, however, that genetic predisposition
plays a role in suicide alongside individual and social factors. Genetic
studies may offer some insight into the biological basis of suicidality
but genome-wide association studies (GWAS) [14–24] or family-based
[25] ﬁndings to date have been limited, perhaps as a result of subse-
quent studies being under-powered or because of diagnostic heteroge-
neity. Recent advances in this area include a GWAS of suicide attempts
in approximately 50,000 individualswith andwithout psychiatric disor-
ders which identiﬁed some suggestive loci [26], replication of a single
GWAS-signiﬁcant ﬁnding on Chromosome 2 [17], nominal evidence
for replication of a SNP on Chromosome 6 [22] and a locus on Chromo-
some 3 [15] and demonstration that suicide attempt and clinically pre-
dicted suicide share signiﬁcant heritability [27].
Our goals in this study were: to identify genetic variants associated
with broadly-deﬁned suicidality in 122,935 participants of the UK
Biobank cohort; to assess for genetic correlations between suicidality
and a range of psychiatric disorders; and to determine whether in-
creased genetic burden for suicidality was associated with bothpsychiatric disorders and completed suicide in a non-overlapping sam-
ple. Broadly-deﬁned suicidality included thoughts and actions of both
suicide and deliberate self-harm, despite current debate over the extent
to which deliberate self-harm and suicidal intent overlap. Our primary
analyses used dimensions of suicidality ordered to reﬂect clinical sever-
ity: from no suicidal thoughts or behaviours, thoughts that life is not
worth living, considered self-harm, actual self-harm and attempted sui-
cide. In secondary analyses, mindful that not all DSH behaviours neces-
sarily carry active suicidal intent, we also conducted additional separate
GWAS analyses of DSH and suicidal ideation/attempts (SIA).2. Materials and methods
2.1. Sample description
UK Biobank is a large general population cohort. Between 2006 and
2010, approximately 502,000 participants (age range 37–73 years)
were recruited and attended one of 22 assessment centres acrossmain-
land UK [28,29]. Comprehensive baseline assessments included
sociodemographic characteristics, cognitive abilities, lifestyle and mea-
sures of mental and physical health status (Supplementary Methods
and Supplementary Fig. 1). To maximise sample homogeneity, only
white British participants were included in the current analysis. In-
formed consent was obtained by UK Biobank from all participants.
This studywas carried out under the generic approval from the NHSNa-
tional Research Ethics Service (approval letter dated 13 May 2016, Ref
16/NW/0274) and under UK Biobank approval for application #6553
“Genome-wide association studies of mental health” (PI Daniel Smith).2.2. Suicidality phenotypes
Suicidality groups were based on four questions from the self-harm
behaviours section of the online mental health (‘Thoughts and Feelings’)
questionnaire administered in 2016/2017: (http://biobank.ctsu.ox.ac.
uk/crystal/label.cgi?id=136 and Supplementary Methods [30]). Non-
overlapping categories of increasing severity of suicidality were de-
rived: ‘no suicidality’ controls; ‘thoughts that life was not worth living’;
‘ever contemplated self-harm or suicide’; ‘acts of deliberate self-harm
not including attempted suicide’; ‘attempted suicide’. If participants
met criteria for more than one category they were assigned to the
most severe category. Those in the lowest category were required to
have answered “no” to all the questions. Linkage to death certiﬁcation
(until February 2016) identiﬁed a separate sub-group of participants
classiﬁed as ‘completed suicide’ (deﬁned as primary cause of death by
intentional self-harm, ICD codes X60-X84; N = 137). The latter group
was not used in the ordinal GWAS but rather was used in a separate
analysis to test for association with genetic loading for suicidality. Par-
ticipants were classiﬁed based on the most extreme form of suicidality
that they reported and placed within the ‘no suicidality’ group if they
responded negatively to all self-harm and suicidality questions. Those
whopreferred not to answer any of the questions (0·7%)were excluded
from analysis.2.3. Genotyping, imputation and quality control
In July 2017 UK Biobank released genetic data for 487,409 individ-
uals, genotyped using the Affymetrix UK BiLEVE Axiom or the
Affymetrix UK Biobank Axiom arrays (Santa Clara, CA, USA) [29].
These arrays have over 95% content in common. Pre-imputation quality
control, imputation and post-imputation cleaning were conducted cen-
trally by UK Biobank (described in the UK Biobank release documenta-
tion [28,29]. Fully imputed genetic data released in March 2018 were
used for this study, therefore a total of 8,930,390 SNPs were available
for analysis.
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For each GWAS, we excluded at random one person from each re-
latedpair of individualswith a kinship coefﬁcient N 0·042 (second cous-
ins) that have valid phenotypes, therefore the number of controls and
participants within each suicidality level is different for each analysis
(Supplementary Methods and Supplementary Figs. 1 and 2).
The primary GWAS included 122,935 individuals. Of these, 83,557
were classiﬁed as controls (category 0), 21,063 were classiﬁed in the
‘thoughts that life is not worth living’ group (category 1), 13,038 in
the ‘thoughts of self-harm’ group (category 2), 2498 in the ‘actual self-
harm’ group (category 3), and 2666 in the ‘attempted suicide’ group
(category 4).
For the secondary analyses, two further ordinal GWAS were con-
ducted. For DSH, the categories of controls, (N= 84,499), ‘thoughts of
self-harm’ (N = 13,203) and ‘actual self-harm’ (N = 2532) were
assessed. For SIA, the categories of controls (N = 84,167), ‘thoughts
that life is not worth living’ group (N=21,234) and ‘attempted suicide’
(N= 2689) were assessed.
Analyses were performed in R (Version 3.1) using the clm function
of the ordinal package [31] treating the multilevel suicidality, DSH or
SIA outcome variable as an ordinal variable. Models were adjusted for
age, sex, genotyping chip and UK Biobank-derived genetic principal
components (GPCs) 1–8. For sensitivity analyses, a variable for psychiat-
ric diagnosis was included as a covariate (where psychiatric diagnosis
was deﬁned as likely or self-reported bipolar disorder (BD), Generalized
Anxiety Disorder (GAD) and Major Depressive Disorder (MDD) and
schizophrenia (SZ)) [30,32]. Further sensitivity analyses also included
self-reported childhood sexual abuse as a covariate [33]. Genome-
wide signiﬁcance was set at P b 5 × 10−8 and plots were generated
using FUMA [34].
2.5. Polygenic Risk score (PRS) variables for suicidality, mood disorders and
related traits
Polygenic risk scores (PRS)were calculated from the primary ordinal
suicidality GWAS summary statistics after pruning based on linkage dis-
equilibrium (Supplementary Methods). SNPs were included in the PRS
if they met p-value thresholds of p b 5 × 10−8, p b 5 × 10−5, p b 0·01
p b 0·05, p b 0·1 or p ≤ 0·5 (Supplementary Methods). PRS deciles
were computed using STATA (version 12, STATACorp) and modelling
of associations between the PRS and completed suicide was analysed
with logistic regression, adjusting for age, sex, chip and GPCs 1–8. In
this analysis, cases were individuals classiﬁed as ‘completed suicide’ (n
= 127), and controls were those recorded as category 0 in the ordinal
variable but who had been excluded from the GWAS due to relatedness
(n=5330). It should be noted that the category 0 individuals herewere
related to individuals across the spectrum of suicidality in the GWAS,
thus are more representative of the general population distribution of
PRS than the true “no suicidality” distribution. Therefore this analysis
is a conservative approach, being biased towards the null. Associations
between the PRS and risk of mood disorders and related traits were
also assessed (Supplementary Methods). The traits tested (BD, MDD,
mood instability, and risk-taking behaviour) were selected based on
prior evidence of relevance to suicidality, therefore the threshold for sig-
niﬁcance was set at p b 0·05.
2.6. SNP heritability and genetic correlation analyses
LinkageDisequilibriumScore Regression (LDSR) [35]was used to es-
timate the SNP heritability (h2SNP) of ordinal suicidality, DSH and SIA.
LDSR was also used to calculate genetic correlations with suicide at-
tempt, psychiatric disorders and related traits (Supplementary
Methods). The resulting genetic correlation P-values were false discov-
ery rate (FDR)-corrected to compensate for multiple testing.2.7. Gene-based analysis
The ordinal GWAS results were also considered under a gene-based
approach, using MAGMA [36], as implemented in FUMA [34].2.8. Exploration of known biology
The Variant Effect Predictor web-based tool [37], GTEx database [38]
and BRAINEAC dataset (http://braineac.org/)were interrogated to try to
identify genes (based on expression quantitative trait loci, eQTLs) or
mechanisms through which associated SNPs might be acting (Supple-
mentary Methods). The GWAS catalogue (https://www.ebi.ac.uk/
gwas/) and NCBI Gene https://www.ncbi.nlm.nih.gov/gene/) were que-
ried for each of the suicidality-associated SNPs and genes reported here.3. Results
3.1. Sociodemographic characteristics
Sociodemographic, clinical and health-related behaviour measures
for each of the suicidality categories are shown in Supplementary
Table 1. As expected, a gradient of increasing suicidality was found for
increasing levels of social deprivation, living alone, current or previous
smoking, parental depression and chronic pain. There were also sub-
stantial differences by sex: females accounted for 68·3% of those who
reported attempted suicide but only 27·6% of completed suicides. A
large proportion of thosewho had attempted suicide (85·1%) had a his-
tory of MDD, compared to only 14·9% of controls. Similarly, 75·8% of
thosewith a suicide attempt also reported childhood trauma, compared
to 39·0% of controls.3.2. Primary ordinal GWAS of suicidality
The results of the ordinal GWAS of suicidality are presented in
Table 1, Supplementary Table 2 and Fig. 1A. The GWAS results showed
some inﬂation of the test statistics from the null (λGC = 1·16, Fig. 1A,
inset) but this was not signiﬁcant given the sample size used (λGC
1000 = 1·004). LDSR demonstrates that polygenic architecture, rather
than unconstrained population structure, is the likely reason for this
(LDSR intercept = 1·02, SE = 0·0075). SNP heritability was estimated
by LDSR as being 7·6% (observed scale h2SNP = 0·076; SE = 0·006).
We identiﬁed three independent loci associated with suicidality
(Table 1, Supplementary Table 2 and Fig. 1A): one on chromosome 9
(index SNP rs62535711, Fig. 2A) within the gene ZCCHC7; a second on
chromosome 11 (index SNP rs598046, Fig. 2B) located within CNTN5;
and a third on chromosome 13 (index SNP rs7989250, Fig. 2C). Condi-
tional analyses (SupplementaryMethods) inwhich the lead SNPwas in-
cluded as a covariate demonstrated no signiﬁcant secondary association
signals at these loci (the most signiﬁcant additional SNP on chromo-
some 9 was rs999510, p = 0·0008; that on chromosome 11 was
rs608820, p= 0·0005; and that on chromosome 13 was rs9564176, p
=0·003). Effect allele frequencies by suicidality category are presented
in Supplementary Table 3. Adjustment of the GWAS for psychiatric dis-
orders had little or no effect on the observed associations (Fig. 1B and
Supplementary Table 2), whilst adjustment for childhood sexual abuse
rendered all associations null (Supplementary Fig. 3).
It is notable that within the recently-reported GWAS of suicide at-
tempt in aDanish sample [26], rs62535711 and rs7989250were not sig-
niﬁcant (p = 0·278 and p = 0·152 respectively) but rs598046 was
reported as borderline signiﬁcant (G allele, Beta 0·041, SE 0·021 p =
0·051).
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suicide’
Demographic characteristics of the controls in this analysis were
comparable to those included in the GWAS (Supplementary Table 1).
Individuals within the completed suicide group followed a similar pat-
tern of increasing deprivation,more childhood trauma and higher prev-
alence of mood disorders observed across the categories of increasing
suicidality (Supplementary Table 1). We investigated whether greater
genetic loading for suicidality, indexed by PRS for suicidality, was asso-
ciated with completed suicide. Overall, higher values of suicidality PRS
were associated with an increased risk of completed suicide at all but
one of the PRS signiﬁcance thresholds assessed (for example, p-thresh-
old 0·05: OR 1.23, 95%CI 1·06–1·41, FDR-adjusted p= 0·04, Table 2).
3.4. Genetic loading for suicidality and mood disorders
PRS for suicidality also demonstrated consistent signiﬁcant associa-
tions with mood disorders (BD and MDD) and related traits (mood in-
stability, neuroticism, and risk-taking propensity), across most of the
signiﬁcance thresholds assessed (Supplementary Table 4).
3.5. Secondary GWAS analyses
The ordinal GWAS of DSH (comprising controls, contemplated self-
harm and actual self-harm) identiﬁed no SNPs at genome-wide signiﬁ-
cance (Supplementary Fig. 4A) and adjustment for psychiatric diagnosis
had little impact on these results (Supplementary Fig. 4B): themost sig-
niﬁcant association was with rs4521702-T, Beta−0·01162, SE 0·0218,
p = 9·56 × 10−8; and Beta−0·01159, SE 0·0218, p = 1·10 × 10−7,
without and with adjustment for psychiatric diagnosis, respectively.
The ordinal GWAS of SIA (comprising controls, ‘suicidal ideation’,
and ‘suicide attempts’) also identiﬁed no SNPs at genome-wide signiﬁ-
cance (Supplementary Fig. 5A), however adjustment for psychiatric dis-
orders did identify a genome-wide signiﬁcant singleton SNP
rs116955121 (Supplementary Fig. 5B–C and Supplementary Table 2).
In the recent Danish GWAS of suicide attempt [26], rs116955121 was
not signiﬁcant (p= 0·509).
3.6. Genetic correlation analyses
When considering thewhole genome (rather than SNPs selected for
association with suicidality, as is the case for the PRS), we observed sig-
niﬁcant genetic correlations between suicidality (primary analysis) and
attempted suicide, and between suicidality and all of the major psychi-
atric disorders and traits we assessed (Table 3). The strongest genetic
correlations were observed for MDD (rg 0·81), Anxiety disorder (rg
0.75), neuroticism (rg 0·63) and mood instability (rg 0·50). DSH dem-
onstrated similar genetic correlations with attempted suicide and with
psychiatric disorders and related traits as those observed for suicidality
(Table 3). In contrast, for SIA, signiﬁcant genetic correlations were ob-
served only for MDD, schizophrenia, neuroticism and mood instability
(Table 3).
3.7. Gene-based analysis
Gene-based analysis was used to identify genes containing potential
composite association signals that were not identiﬁed by the individual
SNP analysis, but which might nevertheless contribute to biological
mechanisms underlying suicidality. Gene-based analysis highlighted
CNTN5, ADCK3/COQ8A, CEP57 and FAM76B and DCC for suicidalityFig. 1.Manhattan plot of GWAS of ordinal suicidality in UK Biobank (N=122,935): A) adjusted
chip, population structure and psychiatric disorders. Dashed red line= genomewide signiﬁcan
= theoretical distribution under the null hypothesis of no association.(primary analysis, Supplementary Fig. 6), EIF4A1 and SENP3 and DCC
for DSH (Supplementary Fig. 7) and CDKAL1, CNTN5, and ADCK3/
COQ8A for SIA (Supplementary Fig. 8). Regional plots for these genes
(except for CNTN5,whichwas also identiﬁed in the SNP-based analysis)
are presented in (Supplementary Fig. 9).
3.8. Biology of the suicidality-associated loci
Suggested functions of genes within the suicidality-associated loci
are presented in Supplementary Table 5 and the Supplementary Results.
Notable ﬁndings were the chromosome 11 locus located within CNTN5,
a very large gene expressed predominantly in brain in adults (Fig. 2D);
eQTL analysis supported the possible involvement of several candidate
genes on chromosome 9 (Supplementary Fig. 10 and Supplementary
Results), and, in combination with the gene-based analysis, additional
candidate genes on chromosome 11 (CEP57; Supplementary Table 6)
and on chromosome 18 (DCC). These genes and nearby variants have
previously been associatedwith a variety of relevant traits (Supplemen-
tary Table 7). Of the SNPs with suggestive evidence for association
(GWAS p b 1 × 10−5) with suicidal behaviour in other studies, 29
were available in our analysis and ﬁve of these demonstrated nominal
(p b 0·05) association with suicidality in this study (Supplementary
Table 8), although only one of these, rs72940689, had a direction of ef-
fect consistent with that given in the previous report [26].
4. Discussion
4.1. Main ﬁndings
Using a very large population-based cohort, we identiﬁed multiple
genetic loci associatedwith suicidality.We also found that increased ge-
netic burden for suicidality was associated with increased risk of com-
pleted suicide within a non-overlapping sub-sample and there were
consistent genetic correlations with a wide range of psychiatric disor-
ders and psychopathological traits, particularly MDD and anxiety disor-
ders. Separate GWAS analyses of DSH and SIA identiﬁed one additional
signal (for SIA) and suggested that the genetic architecture of DSH is
likely to be distinct from that of SIA. Genetic correlations betweenmen-
tal illness andDSHor SIA also differed.More generally, the consistent ef-
fect size and direction of the association of rs598046-G (CNTN5) with
suicide attempts in an independent cohort [26], and our nominal repli-
cation of a SNP reported by Erlangsen (rs7862648) is of interest [26].
In line with our evidence that suicidality is polygenic, inclusion of
more SNPs (using more relaxed p-value thresholds) within a PRS typi-
cally demonstrates more signiﬁcant effects in contrast to the stricter
thresholds used becausemore information and power is provided by in-
cluding a greater number of SNPs. Currently there is no agreed thresh-
old that should be considered in these analyses, therefore we reported
several PRS analyses. Future work on PRSs for suicidality should seek
to identify thresholds that optimally facilitate stratiﬁcation of clinical
and non-clinical populations.
4.2. Comparisons with previous studies
Direct comparisonwith previous studies is hindered by the radically
different study design reported here. Nonetheless, we have tried to align
our ﬁndings with those previously reported.
This is the largest GWAS of suicidality to date and the ﬁrst to con-
sider a broad spectrum of suicidal behaviours. The loci previously re-
ported for suicidal behaviours do not overlap with those identiﬁed
here [14–26]. However, consistent (albeit borderline or nominal)for age, sex, genotyping chip and population structure, B) adjusted for age, sex, genotyping
ce threshold. Inset: QQ plot for genome-wide association with ordinal suicidality. Red line
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Table 1
Lead SNPs at loci associated with ordinal suicidality at GWAS signiﬁcance.
Analysis SNP CHR POS A1 A2 BETA SE P A1Fa SNPs_gwasb SNPs_suggb
Ordinal suicidality rs62535711 9 37,174,829 T C 0.105 0.018 1.29E-08 0.056 15 57
rs598046 11 99,516,468 T G 0.053 0.009 1.07E-08 0.319 34 370
rs7989250 13 64,900,801 A C −0.052 0.009 3.49E-08 0.322 1 5
Where: A1, effect allele; A2, other allele; A1F, effect allele frequency; Aligned to Human Genome assembly GRCh37, Chr9 locus, 9:36999369–37,360,767; Chr11 locus,
11:99392678–99,588,751; Chr13 locus, 13:64900801–65,036; Chr6 locus, 6:140442326–140,895,470; SIA, suicidal ideation or attempt.
a Calculated in whole cohort.
b Within the region deﬁned by suggestive signiﬁcance (P b 1 × 10–5).
Table 2
Increasing burden of suicidal behaviour-associated variants signiﬁcantly associated with
completed suicide.
Threshold OR L95 U95 P FDR-adj P
5 × 10−8 1.07 −0.10 0.24 0.410 0.410
5 × 10−5 1.20 0.01 0.35 0.041 0.049
0.01 1.22 0.02 0.38 0.026 0.390
0.05 1.26 0.05 0.41 0.011 0.034
0.1 1.27 0.06 0.42 0.008 0.034
0.5 1.25 0.03 0.41 0.021 0.039
Where: Threshold, GWAS P threshold of the SNPs included in the suicidality PRS; OR, odds
ratio; L95, lower 95% conﬁdence interval; U95, upper 95% conﬁdence interval; Z, test sta-
tistic, P, P value for analysis; FDR-adj P, false discovery rate adjusted P. Signﬁcance was set
at P b 0.05.
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suicide attempts [26] and one of their lead SNPs in this study is
compelling.
Most previous genetic studies of suicidal behaviour and completed
suicide (Supplementary Table 8) have been conducted in cohorts with
knowndiagnoses ofmajormental illness, thereby controlling formental
illness. In this study, sensitivity analysis controlling (by adjustment) for
mental illness had negligible effects on the primary suicidality results,
however an additional signal was identiﬁed for SIA in secondary analy-
ses. It is likely that the various aspects of suicidality have complex rela-
tionships with different mental illnesses. Therefore, we cannot exclude
the possibility that the results might have been driven by the mixed
and different genetic loadings for psychiatric disorders between suicidal
and non-suicidal participants. A further sensitivity analysis adjusting for
mental illness and childhood sexual abuse rendered all associationsnull,
however as childhood sexual abuse is strongly associated with mental
illness, this model could be considered overly conservative.
In addition, the limited overlap between suicidality-associated loci
identiﬁed across these studies also likely reﬂects substantial differences
in recruitment protocols, participant characteristics (including the mix
of psychiatric diagnoses) and variation in the methods of assessment
of suicidal behaviour. Recently, a general population study in Denmark
of suicide attempts identiﬁed genetic loci at genome-wide signiﬁcance
[26]. Our study extends this approach by investigating a broader pheno-
type within our primary analysis, as well as the speciﬁc impact of DSH
versus SIA in secondary analyses. In line with a Research Domain
Criteria (RDoC) approach, we used the full spectrum of suicidal
thoughts and behaviours assessed within a predominantly non-clinical
population. The fact that increased genetic burden for suicidalitywas as-
sociated with increased risk of completed suicide in a separate sub-
sample represents an important validation of our suicidality phenotype.
The genetic correlationwithMDDwas strong, but the incomplete over-
lap, and the fact that the GWAS results were largely unchanged by ad-
justment for mental health disorder status, supports the hypothesis
that at least some of the genetic predisposition to suicidal ideation
and behaviours may be distinct from that for MDD [18].
The SNP-based heritability reported here for suicidality (7.6%) is
more than that reported for suicide attempts (4.6%) [26], however
both of these are lower than heritability estimates from family studies
[12], which is consistent with ﬁndings from most other complex traits
studied to date.
4.3. Biology
The known biology of the suicidality-associated loci (Supplementary
Results) highlights three interesting candidate genes: CNTN5, CEP57 and
DCC. CNTN5 encodes contactin 5 (also known as NB-2), which is a goodFig. 2. Regional plots for GWAS signiﬁcant loci and CNTN5 tissue expression: A) ZCCHC7 locus
according to position (X axis) and strength of association (Y Axis, left); Purple colouring indic
index SNP, as per the colour key; Recombination rate is presented as a pale blue line graph
location (X axis) and direction of transcription (arrows). D) Tissue expression proﬁle of CN
(TPM; standardised transcripts per million reads) provided on the Y-axis. Box plots represen
range and dots representing outliers.functional candidate. CNTN5 is a glycosylphosphatidylinositol (GPI)-an-
chored extracellular cell adhesion protein of the immunoglobulin su-
perfamily, thought to have a role in the formation and maintenance of
brain circuitry [39]. Centrosomal protein of 57 kDa (CEP57, encoded
by CEP57) is important for cell division, with loss of function variants
causing a mosaic variegated aneuploidy syndrome, which can include
brain abnormalities and mental retardation (OMIM #607951 and
#614114). The netrin 1 receptor (encoded by DCC) has been robustly
associated with depression [40], schizophrenia [41] and related traits
[42]. Speculation as to how variation in these genes act to inﬂuence
these related traits is difﬁcult because of incomplete understanding of
the functions of these genes in the brain during development and aging.4.4. Strengths and limitations
This is the largest genetic study of suicidality in a population sample
reported to date butwe acknowledge some limitations to thiswork. The
nature of the data collected did not allow us to distinguish between pu-
tative subtypes of suicide, such as stress-responsive and non-stress-
responsive suicidality [43]. In addition, both recruitment bias and recall
bias are possiblewithin theUKBiobankdataset. Survivor biasmight also
inﬂuence our ﬁndings, due to the relatively older age at recruitment,
however this would likely lead to more conservative effect estimates.
We also recognise that the questions used to create the ordinal
suicidality phenotype mean that some individuals with either self-
harm ideation/behaviour or suicidal ideationmight be included at levels
higher or lower than their suicidality predisposition merits. Our SNP
heritability estimates were similar to those reported for other complex
psychiatric phenotypes such asMDD [44] and the overlapwith clinically
relevant phenotypes (at the levels of loci, PRS and whole-genome ge-
netic correlations) all suggest that our ﬁndings are robust.on Chr9, B) CNTN5 locus on Chr11, C) Chr13 locus, where: SNPs (each point) are aligned
ates the index SNP, with other colours representing linkage disequilibrium (r2) with the
in the background (Y axis, right); Genes are presented below the association plot by
TN5, where tissues are arranged alphabetically along the X-axis and expression level is
t median and interquartile range, with error bars demonstrating 1.5× the interquartile
Table 3
Genetic correlations of suicidality with psychiatric disorders and related traits.
Trait Suicidality DSH SIA
rg se z p FDR-P rg se z p FDR-P rg se z p FDR-P
Attempted suicide 0.57 0.096 5.98 2.23E-09 6.24E-09 0.624 0.106 5.8897 3.87E-09 9.03E-09 −0.012 0.182 −0.068 9.46E-01 9.83E-01
MDD 0.81 0.04 18.66 1.01E-77 1.41E-76 0.79 0.05 14.48 1.68E-47 2.35E-46 0.46 0.11 4.07 4.76E-05 2.22E-04
Neuroticism 0.63 0.04 16.48 5.51E-61 3.86E-60 0.57 0.05 12.09 1.26E-33 8.82E-33 0.56 0.12 4.77 1.80E-06 1.26E-05
Mood Instability 0.50 0.03 16.06 4.53E-58 2.11E-57 0.43 0.04 11.73 8.50E-32 3.97E-31 0.53 0.11 5.01 5.42E-07 7.59E-06
Schizophrenia 0.32 0.04 8.70 3.19E-18 1.12E-17 0.31 0.04 7.02 2.25E-12 7.88E-12 0.28 0.09 2.96 3.06E-03 1.07E-02
Bipolar disorder 0.27 0.05 5.28 1.26E-07 2.94E-07 0.27 0.06 4.34 1.45E-05 2.26E-05 0.19 0.12 1.55 1.21E-01 3.39E-01
Risk-taking behaviour 0.20 0.04 5.05 4.44E-07 7.77E-07 0.25 0.04 6.00 1.93E-09 5.40E-09 0.00 0.08 0.02 9.83E-01 9.83E-01
Anxiety disorder 0.75 0.17 4.35 1.38E-05 2.15E-05 0.87 0.20 4.41 1.03E-05 1.91E-05 0.31 0.30 1.03 3.05E-01 5.34E-01
ADHD 0.21 0.05 4.29 1.79E-05 2.51E-05 0.23 0.05 4.40 1.09E-05 1.91E-05 −0.12 0.11 −1.17 2.44E-01 5.20E-01
PTSD 0.42 0.16 2.70 6.97E-03 8.87E-03 0.52 0.18 2.82 4.82E-03 6.75E-03 0.16 0.28 0.57 5.70E-01 7.98E-01
Where: DSH, deliberate self-harm; SIA, suicidal ideation or attempt; rg, genetic correlation; se, standard error of genetic correlation; z, test statistic, P, P vlaue for analysis; FDR adj P, false
discovery rate-adjusted P; Signﬁcicance was set at P ≤ 0.05; MDD, major depressive disorder; PTSD, post-traumatic stress disorder; Relative amplitude, quantitative measure of circadian
rythmicity; ADHD, attention deﬁcit hyperactivity disorder.
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This study highlights a component of suicidal predisposition that is
distinct from MDD predisposition and the potential relevance of
CNTN5, CEP57 and DCC to suicidality, further study of which may pro-
vide valuable insight into the underlying biology of suicide. Genetic vul-
nerability to suicide is of course likely to be only a small part of the
overall pathophysiology of what is clearly a highly complex and clini-
cally and psychologically heterogeneous phenotype. A major current
challenge for the ﬁeld of suicide research is to integrate new discoveries
on the genetics of suicide with known psychiatric, social, psychological
and environmental risk factors (such as poverty, substance misuse and
childhood sexual abuse), to develop more sophisticated models of
risk, and ultimately to develop genetically-informed social, psychologi-
cal and public health interventions.
5. Conclusions
In the largest GWAS to date of suicidality to date we identiﬁed sev-
eral new candidate genes that may be relevant to the biology of com-
pleted suicide. We also found substantial genetic correlation between
suicidality and a range of psychiatric disorders and, by ﬁnding an asso-
ciation between genetic loading for suicidality and completed suicide,
we provide preliminary evidence for the potential utility of PRSs for pa-
tient and population stratiﬁcation.We hope these discoveries will facil-
itate new avenues of research on this complex but clinically important
phenotype.
Supplementary data to this article can be found online at https://doi.
org/10.1016/j.ebiom.2019.02.005.
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